 | Up a level |
Kruis, W., Kardalinos, V., Eisenbach, T., Lukas, M., Vich, T., Bunganic, I., Pokrotnieks, J., Derova, J., Kondrackiene, J., Safadi, R., Tuculanu, D., Tulassay, Z., Banai, J., Curtin, A., Dorofeyev, A. E., Zakko, S. F., Ferreira, N., Bjorck, S., Alonso, M. M. Diez, Makela, J., Talley, N. J., Dilger, K., Greinwald, R., Mohrbacher, R. and Spiller, R. (2017). Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrence. Aliment. Pharmacol. Ther., 46 (3). S. 282 - 292. HOBOKEN: WILEY. ISSN 1365-2036
Sellner, L., Oles, M., Anders, S., Zapatka, M., Lukas, M., Slabicki, M., Blume, C., Huellein, J., Stolz, T., Muley, C., Sill, M., Oakes, C. C., Dietrich, S., Merkel, O., Jauch, A., Schrader, A., Hensel, M., Rossi, D., Zirlik, K., Herling, M., Nguyen-Khac, F., Seiffert, M., Dreger, P., von Kalle, C., Ho, A. D., Glimm, H., Duerig, J., Ringshausen, I., Huber, W. and Zenz, T. (2014). SYSTEMATIC DRUG SENSITIVITY SCREENING IN LYMPHOID MALIGNANCIES IDENTIFIES VULNERABILITIES OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH HIGH RISK ABERRATIONS. Haematologica, 99. S. 316 - 317. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078